Can Homeopathic Arsenic Remedy Combat Arsenic Poisoning in Humans Exposed to Groundwater Arsenic Contamination?: A Preliminary Report on First Human Trial

Courtesy :  oxford journal

Can Homeopathic Arsenic Remedy Combat Arsenic Poisoning
in Humans Exposed to Groundwater Arsenic Contamination?:
A Preliminary Report on First Human Trial
Anisur Rahman Khuda-Bukhsh1, Surajit Pathak1, Bibhas Guha1, Susanta Roy KarmakarJayanta Kumar Das1, Pathikrit Banerjee1, Surjyo Jyoti Biswas1, Partha Mukherjee,Nandini Bhattacharjee1, Sandipan Chaki Choudhury1, Antara Banerjee1, Suman Bhadra,Palash Mallick, Jayati Chakrabarti and Biswapati Mandal
Department of Zoology, University of Kalyani and
Directorate of Research, Bidhan Chandra Krishi Viswavidyalaya,
Kalyani-741235, West Bengal, India

Groundwater arsenic (As) has affected millions of people globally distributed over 20 countries. In parts of West Bengal (India) and Bangladesh alone, over 100 million people are at risk, but supply of As-free water is grossly inadequate. Attempts to remove As by using orthodox medicines have mostly been
unsuccessful. A potentized homeopathic remedy, Arsenicum Album-30, was administered to a group of As affected people and thereafter the As contents in their urine and blood were periodically determined. The activities of various toxicity marker enzymes and compounds in the blood, namely aspartate
amino transferase, alanine amino transferase, acid phosphatase, alkaline phosphatase, lipid peroxidation and reduced glutathione, were also periodically monitored up to 3 months. The results are highly encouraging and suggest that the drug can alleviate As poisoning in humans.

Download Link :

                                                   Link 1

                                                    Link 2

Keywords: arsenic toxicity – Arsenicum Album-30 – enzyme biomarkers – homeopathy –
human trial – remedy

Hospital turns to homeopathy over H1N1

Source : Express News Service

BANGALORE: The Rajiv Gandhi Institute for Chest Diseases (RGICD) on Tuesday started using homeopathy for treating people with the H1N1 virus.

The move comes in the backdrop of 21 more people in the state testing positive for swine flu, with 15 of them from Bangalore and three each from Belgaum and Davangere.

Of the 21 cases, 11 were of category A, six of category B and four of category C.

The first day of the new initiative saw more than 300 people with mild symptoms of the disease being screened at the homeopathy counter at RGICD by six doctors of the Government Homeopathy Medical College (GHMC).

“Homeopathic medicine has a history spanning more than 300 years. Based on the core principle that similar cures similar, very dilute solutions are administered to cure the diseases and H1N1 patients are getting relief from our medicines. “The diluted globules help them improve their immunity,” Dr Dassappa of GHMC told Express.

“The integration of allopathy and homeopathy will not only cure the patient but also help strengthen the immunity level to fight the virus,” Dr Sahshidhar Buggi, medical superintendent, RGCID said.

Homeopathic Individualized Q-potencies versus Fluoxetine for Moderate to Severe Depression: Double-blind, Randomized Non-inferiority Trial

Homeopathic Individualized Q-potencies versus Fluoxetine for
Moderate to Severe Depression: Double-blind, Randomized
Non-inferiority Trial

U. C. Adler, N. M. P. Paiva, A. T. Cesar, M. S. Adler, A. Molina, A. E. Padula
and H. M. Calil
Faculdade de Medicina de Jundiaı ´, Homeopathy Graduation Programme, Department of Psychobiology,
Universidade Federal de Sa ˜ o Paulo, Sa ˜ o Paulo, Brazi

Homeopathy is a complementary and integrative medicine used in depression, The aim of
this study is to investigate the non-inferiority and tolerability of individualized homeopathic
medicines [Quinquagintamillesmial (Q-potencies)] in acute depression, using fluoxetine as active
control. Ninety-one outpatients with moderate to severe depression were assigned to receive an
individualized homeopathic medicine or fluoxetine 20mg day–1(up to 40mg day–1) in a pro-
spective, randomized, double-blind double-dummy 8-week, single-center trial. Primary efficacy
measure was the analysis of the mean change in the Montgomery & Asberg Depression Rating
Scale (MADRS) depression scores, using a non-inferiority test with margin of 1.45. Secondary
efficacy outcomes were response and remission rates. Tolerability was assessed with the side
effect rating scale of the Scandinavian Society of Psychopharmacology. Mean MADRS scores
differences were not significant at the 4th (P¼0.654) and 8th weeks (P¼0.965) of treatment.
Non-inferiority of homeopathy was indicated because the upper limit of the confidence interval
(CI) for mean difference in MADRS change was less than the non-inferiority margin: mean
differences (homeopathy–fluoxetine) were 3.04 (95% CI 6.95, 0.86) and 2.4 (95% CI
6.05, 0.77) at 4th and 8th week, respectively. There were no significant differences between
the percentages of response or remission rates in both groups. Tolerability: there were no
significant differences between the side effects rates, although a higher percentage of patients
treated with fluoxetine reported troublesome side effects and there was a trend toward greater
treatment interruption for adverse effects in the fluoxetine group. This study illustrates the
feasibility of randomized controlled double-blind trials of homeopathy in depression and indicates

the non-inferiority of individualized homeopathic Q-potencies as compared to fluoxetine
in acute treatment of outpatients with moderate to severe depression.

Keywords: depression – drug therapy – fluoxetine – homeopathy – integrative and
alternative medicine – non-inferiority – Q-potencies – randomized controlled trial – remission –
response

Source : http://ecam.oxfordjournals.org/ 

Download :

                      Link 1

                      Link 2